<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900502-0031</DOCNO><DOCID>900502-0031.</DOCID><HL>   Technology:   Cambridge BioScience Corp.</HL><DATE>05/02/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B6</SO><CO>   CBCX</CO><IN>MEDICAL SUPPLIES (MDS)</IN><GV>FOOD AND DRUG ADMINISTRATION (FDA)</GV><LP>   WORCESTER, Mass. -- Cambridge BioScience Corp. said thatthe Food and Drug Administration gave it a license for itsRecombigen AIDS antibody detection test.   Cambridge BioScience said the two-hour test, designed forhigh-volume screening at blood banks and laboratories, givesfew false positive readings compared with other tests.</LP><TEXT/></DOC>